Clinical Trials Browser

Phase 1/2 × INDUSTRY × fostamatinib × Clear all

NCT00446095 2016-09-19

Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma

Phase 1/2 Completed

81 enrolled 14 charts

Lymphoma, Lymphoma, Follicular, Lymphoma, Mantle-Cell